Canada & Dane Stevens
7 shared events · Importance 3 · Last updated Sep 23, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Canada: Canada's regulatory environment, where ibogaine is not a controlled substance and Optimi Health has GMP infrastructure and Canada — Health Canada licensing, positions it as an advantageous base for ibogaine manufacture and supply.
Dane Stevens: Dane Stevens, CEO and Co-Founder of Optimi Health, is leading the company's ibogaine initiative and highlights the growing interest and public funding for ibogaine research.
Jun 08, 2026 · 14 articles
Business
Canada: Canada is the country where Optimi Health manufactures its psilocybin and MDMA products at its GMP facility and from where it exports these products internationally.
Dane Stevens: Dane Stevens, CEO and Co-Founder of Optimi Health, expressed pride in the company's commercial supply of psilocybin and highlighted Australia's role as a model for regulated psychedelic medicine.
Jun 29, 2026 · 12 articles
Business
Canada: Canada is the location of Optimi Health's GMP facility where the psilocybin products are manufactured and from where Canada — Health Canada issues export authorizations.
Dane Stevens: Dane Stevens, CEO and Co-Founder of Optimi Health, highlighted the significance of the company's first shipment to the United Kingdom and its unique position as a vertically integrated GMP supplier.
Jun 02, 2026 · 25 articles
Tech
Canada: Canada is the location for the trial sites and the regulatory jurisdiction where Optimi operates under Canada — Health Canada's framework. The trial may bolster Canada's position in psychedelic research.
Dane Stevens: As CEO and Co-Founder of Optimi Health, Dane Stevens announced the trial and emphasized its strategic importance. His leadership is tied to the company's clinical development strategy.
Sep 10, 2026 · 15 articles
Business
Canada: The country hosts Optimi's GMP-compliant manufacturing facilities and its Special Access Program provides patient access to the company's products.
Dane Stevens: As CEO and co-founder, he announced and commented on the appointment, highlighting its importance for the company's clinical trials.
Sep 22, 2026 · 7 articles
Business
Canada: Canada is the location of Optimi Health's GMP-compliant manufacturing facilities in British Columbia and the jurisdiction of its Special Access Program, providing context for the company's operations.
Dane Stevens: Dane Stevens is identified as CEO of Optimi Health and the investor contact for the company; he is not reported to have a specific speaking role at the conference.
Sep 08, 2026 · 6 articles
Tech
Dane Stevens: Dane Stevens, CEO and Co-Founder of Optimi Health Corp., announced the launch of the new microdose psilocybin products, highlighting their consistent dosage for controlled research.
Jun 16, 2026 · 11 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Canada and Dane Stevens interact across events, view sentiment trends, and discover connected entities.
Open Dashboard